Pulike Biological Engineering, Inc. (603566) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Pulike Biological Engineering, Inc.

Why is Pulike Biological Engineering, Inc. ?

Poor Management Efficiency with a low ROCE of 9.93%

The company has been able to generate a Return on Capital Employed (avg) of 9.93% signifying low profitability per unit of total capital (equity and debt)

The company is Net-Debt Free

Poor long term growth as Net Sales has grown by an annual rate of 0.31% and Operating profit at -6.48% over the last 5 years
The company is Net-Debt Free
The company has been able to generate a Return on Equity (avg) of 8.20% signifying low profitability per unit of shareholders funds

Poor long term growth as Net Sales has grown by an annual rate of 0.31% and Operating profit at -6.48% over the last 5 years

With a fall in Net Sales of -2.89%, the company declared Very Negative results in Jun 26

The company has declared negative results for the last 2 consecutive quarters
INTEREST(9M) At CNY 0.37 MM has Grown at 342.24%
NET PROFIT(HY) At CNY 77.63 MM has Grown at -33.55%
OPERATING CASH FLOW(Y) Lowest at CNY 255.56 MM

With ROE of 5.97%, it has a fair valuation with a 1.28 Price to Book Value

Over the past year, while the stock has generated a return of -24.95%, its profits have risen by 25.8% ; the PEG ratio of the company is 0.8
At the current price, the company has a high dividend yield of 6.2

Real-Time Research Report

Verdict Report

How much should you hold?

Overall Portfolio exposure to Pulike Biological Engineering, Inc. should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Pulike Biological Engineering, Inc. for you?

Low Risk, Low Return

Absolute

Risk Adjusted

Volatility

Pulike Biological Engineering, Inc.

-24.85%

-1.30

24.71%

China Shanghai Composite

3.0%

0.22

14.72%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.31%

EBIT Growth (5y)

-6.48%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.26

Sales to Capital Employed (avg)

0.42

Tax Ratio

10.52%

Dividend Payout Ratio

110.91%

Pledged Shares

Institutional Holding

ROCE (avg)

8.24%

ROE (avg)

8.20%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

1.28

EV to EBIT

17.42

EV to EBITDA

10.93

EV to Capital Employed

1.38

EV to Sales

2.54

PEG Ratio

0.83

Dividend Yield

6.24%

ROCE (Latest)

7.95%

ROE (Latest)

5.97%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bearish

Moving Averages

Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

No Trend

Mildly Bearish

OBV

Mildly Bearish

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

0What is working for the Company

NO KEY POSITIVE TRIGGERS

-22What is not working for the Company

INTEREST(9M)

At CNY 0.37 MM has Grown at 342.24%

NET PROFIT(HY)

At CNY 77.63 MM has Grown at -33.55%

OPERATING CASH FLOW(Y)

Lowest at CNY 255.56 MM

RAW MATERIAL COST(Y)

Grown by 8.46% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 2.27 times

NET SALES(Q)

Lowest at CNY 242.03 MM

PRE-TAX PROFIT(Q)

Lowest at CNY 26.57 MM

Here's what is not working for Pulike Biological Engineering, Inc.

Interest

At CNY 0.37 MM has Grown at 342.24%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Net Profit

At CNY 77.63 MM has Grown at -33.55%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (CNY MM)

Pre-Tax Profit

At CNY 26.57 MM has Fallen at -47.53%

over average net sales of the previous four periods of CNY 50.65 MM

MOJO Watch

Near term Pre-Tax Profit trend is very negative

Pre-Tax Profit (CNY MM)

Operating Cash Flow

Lowest at CNY 255.56 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (CNY MM)

Net Sales

Lowest at CNY 242.03 MM

in the last five periods

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Net Sales

At CNY 242.03 MM has Fallen at -8.71%

over average net sales of the previous four periods of CNY 265.12 MM

MOJO Watch

Near term sales trend is negative

Net Sales (CNY MM)

Pre-Tax Profit

Lowest at CNY 26.57 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (CNY MM)

Inventory Turnover Ratio

Lowest at 2.27 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 8.46% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Footer loading